Translational Development Acquisition Corp.

TDAC, TDACU, TDACW · CIK 0001926599 · operating

$0.22+0.00%Last updated Mar 2, 8:48 PM

OverviewFinancial Statements Valuation Models

Key Statistics

Valuation

Market Cap—

P/E—

Fwd P/E—

PEG—

P/S—

P/B—

EV/EBITDA—

EV/Rev—

Profitability

Gross Margin—

Op. Margin—

Net Margin—

ROE1.27%

ROA-0.04%

FCF Margin—

Financial Health

Current Ratio3.09

Debt/Equity-1.12

Free Cash Flow-$851,446

Div. Yield—

Growth & Other

Revenue Growth—

EPS Growth—

Beta—

52W High$0.217

52W Low$0.217

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. (TDACW) is a blank checks company, listed on the Nasdaq. With a market capitalization of $3 million, Translational Development Acquisition Corp. is a micro-cap company. The stock currently trades at $0.22, up 0.00% today, with a 52-week range of $0.22–$0.22.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal Year	EPS Diluted	EPS Basic	YoY
2024	—	—	—

Annual Reports (10-K) · 1 filings

Report Date	Filed	Accession Number
2024-12-31	2025-03-31	0001410578-25-000576	SEC ↗